Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 233

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 233
---
3               |     | F-32 |
| Condensed Consolidated Interim Statements of Stockholders’ Equity (Deficiency) (Unaudited) for the three months ended September 30, 2024 |     | F-33 |
| Condensed Consolidated Interim Statements of Stockholders’ Equity (Unaudited) for the nine months ended September 30, 2023               |     | F-34 |
| Condensed Consolidated Interim Statements of Cash Flows (Unaudited) for the three months ended September 30, 2024 and 2023               |     | F-35 |
| Notes to Condensed Consolidated Interim Financial Statements (Unaudited)                                                                 |     | F-36 |
| Condensed Consolidated Interim Balance Sheets as of December 31, 2023 and June 30, 2023                                                  |     | F-48 |
| Condensed Consolidated Interim Statements of Operations (Unaudited) for the six months ended December 31, 2023 and 2022                  |     | F-49 |
| Condensed Consolidated Interim Statements of Stockholders’ Equity (Deficiency) (Unaudited) for the six months ended December 31, 2023    |     | F-50 |
| Condensed Consolidated Interim Statements of Stockholders’ Equity (Unaudited) for the six months ended December 31, 2023                 |     | F-51 |
| Condensed Consolidated Interim Statements of Cash Flows (Unaudited) for the six months ended December 31, 2023                           |     | F-52 |
| Notes to Condensed Consolidated Interim Financial Statements (Unaudited)                                                                 |     | F-53 |

TUHURA FINANCIAL STATEMENTS

| Report of Independent Registered Public Accounting Firm                                                      
 Consolidated Balance Sheets as of December 31, 2024 and 2023                                                 
 Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023                         |     | F-68 
 F-70 
 F-71 |
|:-------------------------------------------------------------------------------------------------------------|:----|:-----|
| Consolidated Statements of Stockholders’ Equity (Deficit) for the Years Ended December 31, 2024 and 2023     |     | F-72 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023